Tracking and Treating Malignant Melanoma Metastases
1Department of Dermatopathology, CHU Sart Tilman, 4000 Liège, Belgium
2Department of Dermatology, University Hospital, University of Franche-Comté, Inserm U645, IFR 133, 25030 Besançon, France
3Department of Dermatopathology, CHU Sart Tilman, University of Liège, 4000 Liège, Belgium
Tracking and Treating Malignant Melanoma Metastases
Description
The metastatic spread of malignant melanoma (MM) cells is a leading cause of death from skin cancers worldwide. Beyond diagnosing and treating early primary MM, searching for and eradicating MM metastases represent the main endeavour clinicians make for these patients. Potential topics include, but are not limited to:
- Clinical and biological clues for MM progression
- Staging of metastatic MM
- Diagnostic functional imaging
- Immunohistochemistry and molecular studies
- MM stem cells and MM circulating cells
- Mechanisms of MM metastasis
- The 4 routes of MM metastases (intravascular, intramural, perivascular, and interstitial)
- MM metastases and the tumoral growth fraction
- Prognosis of metastatic MM
- Therapy of metastatic MM including anti-MM vaccines
Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/drp/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: